Capital Research Global Investors
AGL icon

Capital Research Global Investors’s Agilon Health AGL Stock Holding History

Capital Research Global Investors’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-27,895
Closed -$4.56M – 417
2024
Q2 		$4.56M Hold
27,895
– – ﹤0.01% 401
2024
Q1 		$4.25M Sell
27,895
-557,132
-95% -$92.7M ﹤0.01% 401
2023
Q4 		$184M Sell
585,027
-198,780
-25% -$71.9M 0.05% 237
2023
Q3 		$348M Buy
783,807
+175,672
+29% +$79.4M 0.1% 178
2023
Q2 		$264M Buy
608,135
+86,394
+17% +$48.6M 0.07% 199
2023
Q1 		$310M Sell
521,741
-15,401
-3% -$8.63M 0.09% 179
2022
Q4 		$217M Sell
537,142
-22,401
-4% -$10.5M 0.07% 207
2022
Q3 		$328M Buy
559,543
+213,695
+62% +$128M 0.11% 160
2022
Q2 		$189M Sell
345,848
-48,867
-12% -$24.7M 0.06% 222
2022
Q1 		$250M Buy
394,715
+61,460
+18% +$31.7M 0.06% 219
2021
Q4 		$225M Buy
333,255
+104,426
+46% +$63.5M 0.05% 237
2021
Q3 		$150M Buy
228,829
+108,695
+90% +$92.8M 0.04% 273
2021
Q2 		$122M Buy
+120,134
New +$105M 0.03% 287

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors's AGL Position: Q3 2024 in Review

Capital Research Global Investors sold out of Agilon Health (AGL) in Q3 2024, closing a stake of 27,895 shares — an estimated $4.56M sold.

Capital Research Global Investors first reported a position in AGL in Q2 2021 and held it in 13 quarters. The position peaked at $348M in Q3 2023. 209 funds tracked by Wall St. Rank hold AGL as of Q3 2024.

  • Capital Research Global Investors reported no remaining Agilon Health position as of Q3 2024 after selling out during the quarter.
  • Capital Research Global Investors sold 27,895 Agilon Health shares in Q3 2024, an estimated $4.56M.
  • Capital Research Global Investors first reported a position in Agilon Health in Q2 2021 and held it in 13 quarters.
  • Capital Research Global Investors's Agilon Health position peaked at $348M in Q3 2023.
  • 209 funds tracked by Wall St. Rank held Agilon Health as of Q3 2024.

Based on Capital Research Global Investors's 13F filing for Q3 2024, filed 13 Nov 2024.